If Robert F. Kennedy Jr. and the Trump administration want to make America healthy again, they should let Medicare cover ...

Coverage of obesity drugs in health plans and the rapid adoption of artificial intelligence are two areas of change that health plans will face during the coming year. A panel of Avalere experts ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

GLP-1 drugs like Ozempic and Wegovy revolutionized weight loss, but their high cost keeps them out of reach for most ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

The FDA's move may change how doctors treat chronic kidney disease, which, according to Ozempic maker Novo Nordisk, affects around 37 million Americans and is one of the leading causes of death in the ...

The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

When Trump ran for president in 2016, he promised to have Medicare negotiate drug prices ... diabetes and heart disease: ...

When Trump ran for president in 2016, he promised to have Medicare negotiate drug prices ... diabetes and heart disease: Rybelsus, Ozempic and Wegovy. These negotiations would have to be implemented ...